T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.01B |
| 2 |
Broadcom
AVGO
|
+$1.49B |
| 3 |
GE Vernova
GEV
|
+$1.19B |
| 4 |
International Paper
IP
|
+$1.05B |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$952M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.31B |
| 2 |
Constellation Energy
CEG
|
+$1.94B |
| 3 |
Qualcomm
QCOM
|
+$1.74B |
| 4 |
NVIDIA
NVDA
|
+$1.71B |
| 5 |
Salesforce
CRM
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.98% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Communication Services | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
LivePerson
LPSN
$34.9M
| $127K | ﹤0.01% |
14,537
+6,180
| +74% | +$59.4K |
|
2702
UNIFI
UFI
$126M
| $127K | ﹤0.01% |
21,432
| – | – |
|
2703
Unisys
UIS
$208M
| $127K | ﹤0.01% |
30,739
+1,878
| +7% | +$9.19K |
|
2704
Savara
SVRA
$1.11B
| $125K | ﹤0.01% |
30,984
-2,708
| -8% | -$12K |
|
2705
Sera Prognostics
SERA
$79.9M
| $124K | ﹤0.01% |
+20,867
| New | +$187K |
|
2706
Shattuck Labs
STTK
$746M
| $124K | ﹤0.01% |
31,903
+12,603
| +65% | +$102K |
|
2707
Alpha Pro Tech
APT
$55.3M
| $123K | ﹤0.01% |
22,263
-637
| -3% | -$3.55K |
|
|
PKST
2708
DELISTED
Peakstone Realty Trust
PKST
| $123K | ﹤0.01% |
11,557
+1,180
| +11% | +$15.5K |
|
|
VTYX
2709
DELISTED
Ventyx Biosciences
VTYX
| $122K | ﹤0.01% |
52,733
+4,706
| +10% | +$19.6K |
|
2710
XBiotech
XBIT
$71.3M
| $122K | ﹤0.01% |
23,625
+6,025
| +34% | +$46.5K |
|
|
CTLP
2711
DELISTED
Cantaloupe
CTLP
| $121K | ﹤0.01% |
18,303
+1,194
| +7% | +$7.74K |
|
2712
Pulse Biosciences
PLSE
$3.22B
| $121K | ﹤0.01% |
10,787
+778
| +8% | +$7.33K |
|
2713
Spruce Power Holding Corp
SPRU
$36M
| $120K | ﹤0.01% |
32,637
| – | – |
|
2714
Bit Digital
BTBT
$527M
| $119K | ﹤0.01% |
37,370
+10,202
| +38% | +$24.9K |
|
|
MURA
2715
DELISTED
Mural Oncology
MURA
| $119K | ﹤0.01% |
37,674
-3,918
| -9% | -$14.4K |
|
|
NAPA
2716
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $119K | ﹤0.01% |
16,717
+1,501
| +10% | +$12.1K |
|
|
SYRS
2717
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $117K | ﹤0.01% |
22,550
| – | – |
|
|
IVAC
2718
DELISTED
Intevac Inc
IVAC
| $116K | ﹤0.01% |
30,000
-6,343
| -17% | -$25K |
|
2719
SelectQuote
SLQT
$129M
| $115K | ﹤0.01% |
41,414
| – | – |
|
2720
Safe Bulkers
SB
$781M
| $114K | ﹤0.01% |
19,490
-455
| -2% | -$2.45K |
|
2721
Resources Connection
RGP
$145M
| $113K | ﹤0.01% |
+10,181
| New | +$114K |
|
2722
Senseonics Holdings Inc
SENS
$413M
| $113K | ﹤0.01% |
14,445
-3,915
| -21% | -$34.9K |
|
2723
Weave Communications
WEAV
$398M
| $113K | ﹤0.01% |
+12,513
| New | +$122K |
|
|
CTEV
2724
Claritev Corp
CTEV
$630M
| $113K | ﹤0.01% |
7,405
-2,773
| -27% | -$66K |
|
2725
OmniAb
OABI
$515M
| $112K | ﹤0.01% |
29,551
+2,708
| +10% | +$12.3K |
|
Similar funds
T. Rowe Price Associates's Q2 2024 Portfolio in Review
As of Q2 2024, T. Rowe Price Associates held 3,089 positions worth $836B, up 2.4% from $816B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2024 filing shows 135 new, 1,850 increased, 836 reduced and 113 closed positions. Its largest new stake was Tempus AI: 5,227,120 shares worth $183M. The largest sale was Microsoft, an estimated $2.31B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2024 buy was Tempus AI: 5,227,120 shares worth $183M.
- T. Rowe Price Associates added most to Apple in Q2 2024, an estimated $4.01B increase.
- T. Rowe Price Associates's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.31B.
- T. Rowe Price Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $570M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $836B portfolio in Q2 2024.
- T. Rowe Price Associates opened 135 new positions and closed 113 in Q2 2024.
- T. Rowe Price Associates's portfolio value rose 2.4% quarter-over-quarter to $836B.
Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.